The effects of hypothermic treatment (32℃) on recovery from ischemia are controversial because the precise mechanisms of hypothermia remain unclear. We demonstrated previously that hypothermia induces beta-catenin-interacting protein 1 (CTNNBIP1) gene expression in vitro. In this study, we evaluated the effects of various hypothermic conditions, including lithium chloride treatment, on CTNNBIP1 gene expression. The results show that short-term hypothermic treatment resulted in relatively higher CTNNBIP1 gene expression than that of a longer treatment. These findings indicate that hypothermia controls CTNNBIP1 gene expression, which may provide clues to develop treatments to recover from and diagnose ischemia.
the brain, leading to an alternative oxygen supply or cerebral hypoxia (Weinachter et al., 1990) . Ischemia eventually leads to brain death due to the poor oxygen/ATP supply. Hypothermia is a strong neuroprotectant that reduces ischemic brain injury, but the detailed mechanisms of its protective effects are not entirely understood (Darwazeh and Yan, 2013) . We showed previously that hypothermic treatment protects against central nervous system oxygen toxicity and ischemic brain injury, which are expected during emergency brain resuscitation of ischemic patients. We also previously demonstrated that hypothermia increases the expression of the beta-catenin-interacting protein 1 (CTNNBIP1) gene (Kwon et al., 2014) . Glycogen synthase kinase-3β (GSK-3β)
is an important cell survival signaling protein that activates hypoxia-inducible factor-1 and inhibits apoptosis (Li et al., 2011) . GSK-3β induces phosphorylation of β-catenin, which activates β-catenin-mediated gene expression, which is critical for β-catenin stability (Ray et al., 2015) . β-catenin knockout results in apoptosis, whereas β-catenin overexpression prevents cell death (Holowacz et al., 2011) . It has also been reported that hypothermic treatment decreases β-catenin degradation after ischemia (Zhang et al., 2008) .
CTNNBIP1 is recognized by leucine zipper tumor suppressor 2, which complexes with CTNNBIP1 and modulates the β-catenin signaling pathway (Stow, 2004) . CTNNBIP1 negatively regulates Wnt signaling by inhibiting interactions with β-catenin (Cruciat et al., 2014) . Our previous data showed that CTNNBIP1 gene expression is controlled by hypothermia, suggesting that heat acclimation treatment 
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-161 -could be effective in ischemia (Kwon et al., 2014) . In this using Taq DNA polymerase. CTNNBIP1 mRNA expression was increased gradually about two-fold in a time-dependent manner until 7 h compared to that of the control (Fig. 1A) . However, expression decreased by about half during days 1~3 of hypothermia exposure (Fig. 1B) . These results show that hypothermia increased CTNNBIP1 gene expression only in the shortterm period (≤ 1 day). We also tested the effect of 1, 3, and 5 h exposure to normal temperature after 2 days of hypothermic treatment on CTNNBIP1 gene expression ( Fig. 2A) .
The resulting CTNNBIP1 gene expression was not repaired until its control. As shown in Fig. 1A , short-term hypothermic treatment increased CTNNBIP1 gene expression.
To know, in this time, repeat treatments both 2 h normal temperature and 2 h hypothermia, which how to effect for the CTNNBIP1 gene expression (Fig. 2B) . These results show that CTNNBIP1 gene expression increased about fourfold after two treatments. We also examined the effects of lithium chloride (LiCl), a well-known GSK-3β inhibitor, on CTNNBIP1 gene expression during hypothermic treatment (Fig. 3) . LiCl reduces hypothermia through Tau hyperphosphorylation and enhances β-catenin protein expression (Meffre et al., 2015) . In summary, this is the first study to demonstrate that short-term hypothermic treatment upregulates CTNNBIP1 gene expression and that repeated-hypothermic treatment 
